Amgen Inc banner

Amgen Inc
HKEX:4332

Watchlist Manager
Amgen Inc Logo
Amgen Inc
HKEX:4332
Watchlist
Price: 1 000 HKD 125.23% Market Closed
Market Cap: HK$1.1T

Wall St Price Targets

Price Targets Summary
Amgen Inc

Wall Street analysts forecast Amgen Inc stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Amgen Inc is 953.85 HKD with a low forecast of 522.14 HKD and a high forecast of 1 158.92 HKD.

Lowest Forecast
Price Target
522.14 HKD
48% Downside
Average Forecast
Price Target
953.85 HKD
5% Downside
Highest Forecast
Price Target
1 158.92 HKD
16% Upside
Amgen Inc Competitors:
Price Targets
IBEX
Ibex Ltd
8% Upside
TENB
Tenable Holdings Inc
-13% Downside
BRI
Britania PCL
4% Upside
MEDP
Medpace Holdings Inc
-22% Downside
EOLS
Evolus Inc
150% Upside

Revenue
Forecast

6% / Year
Past Growth
3% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
6% / Year
Past Growth
3% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 8 years is 3%.

Gross Profit
Forecast

5% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss
5% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 5%. The projected CAGR for the next 8 years is 5%.

Operating Income
Forecast

5% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-19%
Average Miss
5% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-19%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 5%. The projected CAGR for the next 8 years is 8%.

Pre-Tax Income
Forecast

5% / Year
Past Growth
21% / Year
Estimated Growth
Estimates Accuracy
-23%
Average Miss
5% / Year
Past Growth
21% / Year
Estimated Growth
Estimates Accuracy
-23%
Average Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 5%. The projected CAGR for the next 3 years is 21%.

Net Income
Forecast

5% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-24%
Average Miss
5% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-24%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 5%. The projected CAGR for the next 8 years is 10%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is Amgen Inc's stock price target?
Price Target
953.85 HKD

According to Wall Street analysts, the average 1-year price target for Amgen Inc is 953.85 HKD with a low forecast of 522.14 HKD and a high forecast of 1 158.92 HKD.

What is the Revenue forecast for Amgen Inc?
Projected CAGR
3%

Over the last 13 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 8 years is 3%.

What is the Gross Profit forecast for Amgen Inc?
Projected CAGR
5%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 5%. The projected CAGR for the next 8 years is 5%.

What is the Operating Income forecast for Amgen Inc?
Projected CAGR
8%

Over the last 13 years, the compound annual growth rate for Operating Income has been 5%. The projected CAGR for the next 8 years is 8%.

What is the Pre-Tax Income forecast for Amgen Inc?
Projected CAGR
21%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 5%. The projected CAGR for the next 3 years is 21%.

What is the Net Income forecast for Amgen Inc?
Projected CAGR
10%

Over the last 13 years, the compound annual growth rate for Net Income has been 5%. The projected CAGR for the next 8 years is 10%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett